PFE
23
7
HRB
57
5
ILMN
42
5
SYK
64
-4
EQT
57
-2
YUM
47
3
XRX
44
3
PLD
56
8
UNP
52
7
SIG
52
3
SYY
53
4
JPM
69
2
PRGO
39
3
DG
6
2
ADSK
70
2
SNA
68
-2
VTR
47
-7
MTB
67
2
PSA
58
2
MLM
57
6
PFE
23
7
HRB
57
5
ILMN
42
5
SYK
64
-4
EQT
57
-2
YUM
47
3
XRX
44
3
PLD
56
8
UNP
52
7
SIG
52
3
SYY
53
4
JPM
69
2
PRGO
39
3
DG
6
2
ADSK
70
2
SNA
68
-2
VTR
47
-7
MTB
67
2
PSA
58
2
MLM
57
6
Financhill
Back

Adverum Biotechnologies Vs. EyePoint Pharmaceuticals Industry Stock Comparison

Sell
35

ADVM
Adverum Biotechnologies

Last Price:
6.05
Seasonality Move:
22.26%
Buy
61

EYPT
EyePoint Pharmaceuticals

Last Price:
8.94
Seasonality Move:
28.93%
Sell
35
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy, Sell or Hold?

  • The current Adverum Biotechnologies [ADVM] share price is $6.04. The Score for ADVM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ADVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.95. The Score for EYPT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ADVM Stock Price Chart

What is Adverum Biotechnologies's stock price today?

  • The Adverum Biotechnologies share price today is $6.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing buying pressure, which is a positive indicator for future bullish movement.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight buying pressure.

ADVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 31.12 Sell
Chaikin Money Flow: 229906 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.74 - 8.16) Sell
Bollinger Bands (100): (6.72 - 8) Sell

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 41.34 Sell
Chaikin Money Flow: 378625 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.4 - 11.84) Sell
Bollinger Bands (100): (8.13 - 10.51) Sell

ADVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.59 Sell
20-day SMA: 7.29 Sell
50-day SMA: 7.4 Sell
200-day SMA: 9.82 Sell
8-day EMA: 6.5 Sell
20-day EMA: 7.05 Sell
50-day EMA: 7.32 Sell
200-day EMA: 8.77 Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.31 Sell
20-day SMA: 10.76 Sell
50-day SMA: 9.77 Sell
200-day SMA: 13.45 Sell
8-day EMA: 9.35 Sell
20-day EMA: 10.02 Sell
50-day EMA: 9.94 Sell
200-day EMA: 11.46 Sell

Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.56 per share, and an increase next year of $0.34 per share.

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.

Adverum Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):